{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:59:46Z","timestamp":1778047186270,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79808-y","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T07:23:21Z","timestamp":1733383401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["QTc interval prolongation and its associated factors among HIV infected patients on ART in Mettu Town"],"prefix":"10.1038","volume":"14","author":[{"given":"Zewudu","family":"Befkadu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betemariam","family":"Girma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"79808_CR1","unstructured":"World Health Organisation (WHO). HIV and AIDS Key facts. 86. (2023)."},{"key":"79808_CR2","doi-asserted-by":"crossref","unstructured":"Moyo, E. et al. Key populations and Sub-saharan Africa\u2019s HIV response. Front. Public. Heal 11, (2023).","DOI":"10.3389\/fpubh.2023.1079990"},{"key":"79808_CR3","unstructured":"USAIDS. HIV \/AIDS. (2022)."},{"key":"79808_CR4","doi-asserted-by":"crossref","unstructured":"Zicari, S. et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses 11, (2019).","DOI":"10.3390\/v11030200"},{"key":"79808_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-020-00266-3","volume":"17","author":"JE Heron","year":"2020","unstructured":"Heron, J. E., Bagnis, C. I. & Gracey, D. M. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res. Ther. 17, 1\u201313 (2020).","journal-title":"AIDS Res. Ther."},{"key":"79808_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2022.42.294.35134","volume":"42","author":"M Kotey","year":"2022","unstructured":"Kotey, M. et al. Chronic comorbidities in persons living with HIV within three years of exposure to antiretroviral therapy at Pantang antiretroviral center in Ghana: A retrospective study. Pan Afr. Med. J. 42, 1\u201321 (2022).","journal-title":"Pan Afr. Med. J."},{"key":"79808_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit, M. et al. Future challenges for clinical care of an ageing population infected with HIV: A modelling study. Lancet Infect. Dis. 15, 810\u2013818 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"79808_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/HIV.S362459","volume":"14","author":"E Woldeyes","year":"2022","unstructured":"Woldeyes, E. et al. Prevalence of clinical cardiovascular disease risk factors among HIV infected patients on anti-retroviral treatment in a Tertiary hospital in Ethiopia. HIV\/AIDS - Res. Palliat. Care. 14, 297\u2013309 (2022).","journal-title":"HIV\/AIDS - Res. Palliat. Care"},{"key":"79808_CR9","first-page":"420","volume":"5","author":"AP Menanga","year":"2015","unstructured":"Menanga, A. P. et al. Patterns of cardiovascular disease in a group of HIV-infected adults in Yaound\u00e9, Cameroon. Cardiovasc. Diagn. Ther. 5, 420\u2013427 (2015).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"79808_CR10","first-page":"1","volume":"2","author":"E Cerrato","year":"2015","unstructured":"Cerrato, E. et al. Cardiovascular disease in HIV patients: From bench to bedside and backwards. Open. Hear. 2, 1\u20137 (2015).","journal-title":"Open. Hear."},{"key":"79808_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","volume":"13","author":"FM Islam","year":"2012","unstructured":"Islam, F. M., Wu, J., Jansson, J. & Wilson, D. P. Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis. HIV Med. 13, 453\u2013468 (2012).","journal-title":"HIV Med."},{"key":"79808_CR12","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","volume":"7","author":"K So-Armah","year":"2020","unstructured":"So-Armah, K. et al. HIV and cardiovascular disease. Lancet HIV. 7, e279\u2013e293 (2020).","journal-title":"Lancet HIV"},{"key":"79808_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-15321-7","volume":"23","author":"W Ruamtawee","year":"2023","unstructured":"Ruamtawee, W., Tipayamongkholgul, M., Aimyong, N. & Manosuthi, W. Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: A systematic review. BMC Public. Health. 23, 1\u20138 (2023).","journal-title":"BMC Public. Health"},{"key":"79808_CR14","first-page":"2205","volume":"33","author":"A Dehlb\u00e6k","year":"2019","unstructured":"Dehlb\u00e6k, A. et al. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV. Wolters Kluwer Heal. 33, 2205\u20132210 (2019).","journal-title":"Wolters Kluwer Heal"},{"key":"79808_CR15","doi-asserted-by":"publisher","unstructured":"Reinsch, N. et al. Prolongation of the QTc interval in HIV\u2014infected individuals compared to the general population. springer 1\u20139 doi: (2017). https:\/\/doi.org\/10.1007\/s15010-017-1053-9","DOI":"10.1007\/s15010-017-1053-9"},{"key":"79808_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325958219833926","volume":"18","author":"M Myerson","year":"2019","unstructured":"Myerson, M., Kaplan-lewis, E., Poltavskiy, E. & Ferris, D. Prolonged QTc in HIV-Infected patients: A need for routine ECG screening. J. Int. Assoc. Provid AIDS Care. 18, 1\u20138 (2019).","journal-title":"J. Int. Assoc. Provid AIDS Care"},{"key":"79808_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/1596-3519.152072","volume":"14","author":"OJ Ogunmola","year":"2015","unstructured":"Ogunmola, O. J., Oladosu, Y. O. & Olamoyegun, M. A. QTCinterval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs. Ann. Afr. Med. 14, 169\u2013176 (2015).","journal-title":"Ann. Afr. Med."},{"key":"79808_CR18","first-page":"1657","volume":"97","author":"MU Sani","year":"2005","unstructured":"Sani, M. U., Okeahialam, B. N. & Jos, F. QTc interval prolongation in patients with HIV and AIDS. J. Natl. Med. Assoc. 97, 1657\u20131661 (2005).","journal-title":"J. Natl. Med. Assoc."},{"key":"79808_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jinf.2006.11.001","volume":"54","author":"P Chinello","year":"2007","unstructured":"Chinello, P. et al. Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients. J. Infect. 54, 597\u2013602 (2007).","journal-title":"J. Infect."},{"key":"79808_CR20","doi-asserted-by":"publisher","first-page":"e0244742","DOI":"10.1371\/journal.pone.0244742","volume":"16","author":"GVT Roozen","year":"2021","unstructured":"Roozen, G. V. T. et al. Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa. PLoS One. 16, e0244742 (2021).","journal-title":"PLoS One"},{"key":"79808_CR21","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","volume":"29","author":"KE Trinkley","year":"2013","unstructured":"Trinkley, K. E., Lee, R., Lien, H. & Yamanouye, K. QT interval prolongation and the risk of torsades de pointes: Essentials for clinicians. Curr. Med. Res. Opin. 29, 1719\u20131726 (2013).","journal-title":"Curr. Med. Res. Opin."},{"key":"79808_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jchf.2019.04.025","volume":"7","author":"RM Alvi","year":"2020","unstructured":"Alvi, R. M. et al. The risk for sudden cardiac death among patients living with heart failure and human immunodeficiency virus. JACC Hear. Fail. 7, 759\u2013767 (2020).","journal-title":"JACC Hear. Fail."},{"key":"79808_CR23","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.hrthm.2015.07.011","volume":"12","author":"MN Niemeijer","year":"2015","unstructured":"Niemeijer, M. N. et al. Consistency of heart rate-QTc prolongation consistency and sudden cardiac death: The Rotterdam study. Hear. Rhythm. 12, 2078\u20132085 (2015).","journal-title":"Hear. Rhythm"},{"key":"79808_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MJT.0b013e3181ad3437","volume":"17","author":"M Singh","year":"2010","unstructured":"Singh, M., Arora, R. & Jawad, E. HIV protease inhibitors induced prolongation of the QT interval: Electrophysiology and clinical implications. Am. J. Ther. 17, 193\u2013201 (2010).","journal-title":"Am. J. Ther."},{"key":"79808_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/aps.2014.165","volume":"36","author":"SN Han","year":"2015","unstructured":"Han, S. N., Sun, X. Y., Zhang, Z. & Zhang, L. R. The protease inhibitor atazanavir blocks hERG K\u2009+\u2009channels expressed in HEK293 cells and obstructs hERG protein transport to cell membrane. Acta Pharmacol. Sin. 36, 454\u2013462 (2015).","journal-title":"Acta Pharmacol. Sin"},{"key":"79808_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.yjmcc.2011.07.017","volume":"51","author":"YL Bai","year":"2011","unstructured":"Bai, Y. L. et al. HIV Tat protein inhibits hERG K\u2009+\u2009channels: A potential mechanism of HIV infection induced LQTs. J. Mol. Cell. Cardiol. 51, 876\u2013880 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"79808_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ihj.2019.11.259","volume":"71","author":"J Liu","year":"2019","unstructured":"Liu, J., Shah, S. K., Basu-ray, I., Garcia-diaz, J. & Khalid, K. QT prolongation in HIV-positive patients: Review article. Indian Heart J. 71, 434\u2013439 (2019).","journal-title":"Indian Heart J."},{"key":"79808_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.pcad.2016.02.008","volume":"58","author":"F Ballocca","year":"2016","unstructured":"Ballocca, F. et al. HIV infection and primary prevention of cardiovascular disease: Lights and shadows in the HAART era. Prog Cardiovasc. Dis. 58, 565\u2013576 (2016).","journal-title":"Prog Cardiovasc. Dis."},{"key":"79808_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/cid\/cis489","volume":"55","author":"S Lang","year":"2012","unstructured":"Lang, S. et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin. Infect. Dis. 55, 600\u2013607 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"79808_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/anec.12162","volume":"16","author":"W Wongcharoen","year":"2014","unstructured":"Wongcharoen, W., Suaklin, S., Tantisirivit, N., Phrommintikul, A. & Chattipakorn, N. QT dispersion in HIV-Infected patients receiving combined antiretroviral Therapy.pdf. Ann. Noninvasive Electrocardiol. 16, 561\u2013566 (2014).","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"79808_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2459\/JCM.0000000000000436","volume":"18","author":"S Gili","year":"2017","unstructured":"Gili, S. et al. Prevalence and predictors of long corrected QT interval in HIV-positive patients: A multicenter study. J. Cardiovasc. Med. 18, 539\u2013544 (2017).","journal-title":"J. Cardiovasc. Med."},{"key":"79808_CR32","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.cardfail.2016.06.174","volume":"22","author":"P Ayyadurai","year":"2016","unstructured":"Ayyadurai, P., Shankar, A., Burchfield, H. & Prolonged, Q. T. Interval and ventricular tachycardia in a cohort of HIV infected African American population. J. Card Fail. 22, S58 (2016).","journal-title":"J. Card Fail."},{"key":"79808_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.55320\/mjz.43.1.307","volume":"43","author":"L Kabwe","year":"2016","unstructured":"Kabwe, L., Lakhi, S., Kalinichenko, S. & Mulenga, L. Prevalence of subclinical cardiovascular disease in healthy HIV infected patients at the University teaching hospital in Lusaka, Zambia. Med. J. Zambia. 43, 12\u201323 (2016).","journal-title":"Med. J. Zambia"},{"key":"79808_CR34","doi-asserted-by":"publisher","unstructured":"Smulyan, H. QT interval: Bazett\u2019s correction corrected. J. Electrocardiol. 1\u20136 https:\/\/doi.org\/10.1016\/j.jelectrocard.2018.08.013 (2018).","DOI":"10.1016\/j.jelectrocard.2018.08.013"},{"key":"79808_CR35","first-page":"982","volume":"53","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju, P. M., Surawicz, B. & Gettes, L. S. AHA \/ ACCF \/ HRS recommendations for the standardization and interpretation of the electrocardiogram. JAC. 53, 982\u2013991 (2009).","journal-title":"JAC"},{"key":"79808_CR36","first-page":"2020","volume":"501","author":"AHA","year":"2018","unstructured":"AHA. American heart association recommendations for physical activity in adults and kids. Heart Org. 501, 2020 (2018).","journal-title":"Heart Org."},{"key":"79808_CR37","unstructured":"World Medical Association. WMA Declaration of Helsinki: Ethical principles for medical research involving human subjects. 353, 1418\u20131419. (1974)."},{"key":"79808_CR38","unstructured":"Cimpaye, E. Electrocardiographic abnormalities among HIV infected adults attending the comprehensive care center at Kenyatta Nationa Hospital, A dessertation submitted in partial fulfillement the award of Master of Medicine in Internal Medicine. Nairobi university repository (2018)."},{"key":"79808_CR39","doi-asserted-by":"crossref","unstructured":"Repolarization, C. et al. The role of inflammation and autoimmunity in Long QT syndrome. 227\u2013251 (2019).","DOI":"10.1007\/978-3-030-22672-5_13"},{"key":"79808_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2015.00026","volume":"2","author":"PE Lazzerini","year":"2015","unstructured":"Lazzerini, P. E., Capecchi, P. L., Laghi-Pasini, F. & Long, Q. T. Syndrome: An emerging role for inflammation and immunity. Front. Cardiovasc. Med. 2, 1\u201317 (2015).","journal-title":"Front. Cardiovasc. Med."},{"key":"79808_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3899\/jrheum.140861","volume":"42","author":"AM Adlan","year":"2015","unstructured":"Adlan, A. M., Panoulas, V. F., Smith, J. P., Fisher, J. P. & Kitas, G. D. Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J. Rheumatol. 42, 421\u2013428 (2015).","journal-title":"J. Rheumatol."},{"key":"79808_CR42","doi-asserted-by":"publisher","first-page":"13289","DOI":"10.1074\/jbc.C400025200","volume":"279","author":"J Wang","year":"2004","unstructured":"Wang, J. et al. Impairment of HERG K\u2009+\u2009channel function by tumor necrosis factor-\u03b1: Role of reactive oxygen species as a mediator. J. Biol. Chem. 279, 13289\u201313292 (2004).","journal-title":"J. Biol. Chem."},{"key":"79808_CR43","doi-asserted-by":"crossref","unstructured":"Lumsden, R. H. & Bloomfield, G. S. The causes of HIV-associated cardiomyopathy: A tale of two worlds. Biomed Res. Int. (2016). (2016).","DOI":"10.1155\/2016\/8196560"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79808-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79808-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79808-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:52:35Z","timestamp":1733395955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79808-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79808"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79808-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30327"}}